Donald R Parfet
CIK 1305641 · Chairman of the Board · last filed 2026-02-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ROK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
APJOHN GROUP LLC
KALAMAZOO, MI 49007
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROK | Director | 14,014 | $391.80 | $5.49M | -$1.27M | 42 | 2026-02-11 |
| MAS | Director | 5,574 | $86.83 | $484.0K | -$428.9K | 22 | 2024-08-05 |
| KELYB | Director | 100,296 | $25.88 | $2.60M | $53.4K | 22 | 2024-05-10 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 1,946 | $54.99 | $107.0K | $0 | 4 | 2019-06-12 |
| Sierra Oncology, Inc. (DNAI) Delisted | Chairman of the Board | 76,444 | — | — | $0 | 5 | 2016-11-10 |
| UNM | Director | 33,835 | $79.77 | $2.70M | $0 | 1 | 2013-05-10 |
Recent Filings · Page 3 of 10
96 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-16 | KELYB | Buy (P) | +14,000 | $248.0K | EDGAR |
| 2021-12-08 | ROK | Grant (A) | +421 | $0 | EDGAR |
| 2021-05-19 | KELYB | Grant (A) | +6,490 | $165.0K | EDGAR |
| 2021-05-14 | MAS | Grant (A) | +2,580 | $0 | EDGAR |
| 2021-02-03 | ROK | Grant (A) | +159 | $0 | EDGAR |
| 2020-11-03 | MAS | Sell (S) | −3,783 | -$205.9K | EDGAR |
| 2020-10-02 | ROK | Grant (A) | +490 | $0 | EDGAR |
| 2020-05-28 | ROK | Gift (G) | −1,744 | $0 | EDGAR |
| 2020-05-28 | ROK | Gift (G) | −1,398 | $0 | EDGAR |
| 2020-05-15 | MAS | Grant (A) | +3,510 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.